MMG Opportunities
1
1M
1
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the MMG Opportunities, startups are often financed by TEDCO, MedTech Innovator, Abell Foundation. The meaningful sponsors for the fund in investment in the same round are TEDCO, Emerald Development Managers, Abell Foundation.
Among the most successful fund investment fields, there are Medical Device, Biotechnology. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Vixiar Medical.
The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2019.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Health Care (1)
- Biotechnology (1)
- Clinical Trials (1)
- Medical Device (1)
- Medical (1) Show 1 more
- Investments by region
-
- United States (1)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Vixiar Medical | 20 Mar 2019 | Biotechnology, Health Care, Robotics, Medical Device, Medical, Clinical Trials | Early Stage Venture | 1M | United States, Maryland, Baltimore |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.